E2F1 and E2F2 induction in response to DNA damage preserves genomic stability in neuronal cells
- PMID: 25892555
- PMCID: PMC4614399
- DOI: 10.4161/15384101.2014.985031
E2F1 and E2F2 induction in response to DNA damage preserves genomic stability in neuronal cells
Abstract
E2F transcription factors regulate a wide range of biological processes, including the cellular response to DNA damage. In the present study, we examined whether E2F family members are transcriptionally induced following treatment with several genotoxic agents, and have a role on the cell DNA damage response. We show a novel mechanism, conserved among diverse species, in which E2F1 and E2F2, the latter specifically in neuronal cells, are transcriptionally induced after DNA damage. This upregulation leads to increased E2F1 and E2F2 protein levels as a consequence of de novo protein synthesis. Ectopic expression of these E2Fs in neuronal cells reduces the level of DNA damage following genotoxic treatment, while ablation of E2F1 and E2F2 leads to the accumulation of DNA lesions and increased apoptotic response. Cell viability and DNA repair capability in response to DNA damage induction are also reduced by the E2F1 and E2F2 deficiencies. Finally, E2F1 and E2F2 accumulate at sites of oxidative and UV-induced DNA damage, and interact with γH2AX DNA repair factor. As previously reported for E2F1, E2F2 promotes Rad51 foci formation, interacts with GCN5 acetyltransferase and induces histone acetylation following genotoxic insult. The results presented here unveil a new mechanism involving E2F1 and E2F2 in the maintenance of genomic stability in response to DNA damage in neuronal cells.
Keywords: ASCAT, CAT antisense; ASE2F1, E2F1 antisense; ASE2F2, E2F2 antisense; DNA damage response; DNA repair; E2F transcription factor; NCS, neocarzinostatin; ODN, oligodeoxynucleotide; genomic stability; mut E2F DO, mutant E2F decoy oligodeoxynucleotide; neuronal cells; wt E2F DO, wild-type E2F decoy oligodeoxynucleotide.
Figures
Similar articles
-
Transcription factor compensation during mammary gland development in E2F knockout mice.PLoS One. 2018 Apr 4;13(4):e0194937. doi: 10.1371/journal.pone.0194937. eCollection 2018. PLoS One. 2018. PMID: 29617434 Free PMC article.
-
Ablation of the transcription factors E2F1-2 limits neuroinflammation and associated neurological deficits after contusive spinal cord injury.Cell Cycle. 2015;14(23):3698-712. doi: 10.1080/15384101.2015.1104436. Cell Cycle. 2015. PMID: 26505089 Free PMC article.
-
E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.Oncogene. 2006 Jan 12;25(2):230-9. doi: 10.1038/sj.onc.1209025. Oncogene. 2006. PMID: 16158053
-
The E2F1 transcription factor and RB tumor suppressor moonlight as DNA repair factors.Cell Cycle. 2020 Sep;19(18):2260-2269. doi: 10.1080/15384101.2020.1801190. Epub 2020 Aug 13. Cell Cycle. 2020. PMID: 32787501 Free PMC article. Review.
-
[Advancement of E2F1 in Common Tumors].Zhongguo Fei Ai Za Zhi. 2020 Oct 20;23(10):921-926. doi: 10.3779/j.issn.1009-3419.2020.101.32. Zhongguo Fei Ai Za Zhi. 2020. PMID: 33070516 Free PMC article. Review. Chinese.
Cited by
-
The effect of metformin on senescence of T lymphocytes.Immun Ageing. 2023 Dec 12;20(1):73. doi: 10.1186/s12979-023-00394-0. Immun Ageing. 2023. PMID: 38087369 Free PMC article.
-
Transcriptional targets of senataxin and E2 promoter binding factors are associated with neuro-degenerative pathways during increased autophagic flux.Sci Rep. 2022 Oct 21;12(1):17665. doi: 10.1038/s41598-022-21617-2. Sci Rep. 2022. PMID: 36271102 Free PMC article.
-
Alteration of E2F2 Expression in Governing Endothelial Cell Senescence.Genes (Basel). 2022 Aug 24;13(9):1522. doi: 10.3390/genes13091522. Genes (Basel). 2022. PMID: 36140689 Free PMC article.
-
Model scenarios for cell cycle re-entry in Alzheimer's disease.iScience. 2022 Jun 7;25(7):104543. doi: 10.1016/j.isci.2022.104543. eCollection 2022 Jul 15. iScience. 2022. PMID: 35747391 Free PMC article.
-
E2F1 Expression and Apoptosis Initiation in Crayfish and Rat Peripheral Neurons and Glial Cells after Axonal Injury.Int J Mol Sci. 2022 Apr 18;23(8):4451. doi: 10.3390/ijms23084451. Int J Mol Sci. 2022. PMID: 35457270 Free PMC article.
References
-
- Leone G, Nuckolls F, Ishida S, Adams M, Sears R, Jakoi L, Miron A, Nevins JR. Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins. Mol Cell Biol 2000; 20:3626-32; PMID:10779352; http://dx.doi.org/10.1128/MCB.20.10.3626-3632.2000 - DOI - PMC - PubMed
-
- He Y, Armanious MK, Thomas MJ, Cress WD. Identification of E2F-3B, an alternative form of E2F-3 lacking a conserved N-terminal region. Oncogene 2000; 19:3422-33; PMID:10918599 - PubMed
-
- Cartwright P, Muller H, Wagener C, Holm K, Helin K. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene 1998; 17:611-23; PMID:9704927 - PubMed
-
- Di Stefano L, Jensen MR, Helin K. E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes. EMBO J 2003; 22:6289-98; PMID:14633988; http://dx.doi.org/10.1093/emboj/cdg613 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
